Figures and Tables.

Dataset #1
Dataset #2 λ 1 = 1.00695 Å λ 2 Table S1 . Statistics describing two original datasets of mercury labeled drug-free mouse Pgp ("Crystal 2") collected at two x-ray wavelengths (λ 1 and λ 2 ) near the Hg LIII absorption edge for MAD phasing. The table was generated from original datasets collected for the mouse Pgp structure published by Aller et al (1). Radiation damage is particularly evident for the last two resolution shells of Dataset #2 (highlighted in yellow and red). Values of ≥ 0.6 are typically considered random.
Figure S1. Plot of amino acid residue number versus distance between corrected Cα and original Cα.
Secondary structure assignment and structural features of P-glycoprotein are highlighted above the graphs (transmembrane helix, TM, intracellular helix, IH, nucleotide binding domain, NBD, Walker A, WA and Walker B, WB). For simplicity, the plot is for "molecule A" of the asymmetric unit since similar values were obtained for "molecule B" due to non-crystallographic symmetry enforced during refinement.
Detailed Changes to Mouse P-glycoprotein X-ray Crystal Structure (unless explicitly stated, "density" referred to below represents experimental electron density produced from our newly phased map, contoured at 1 σ; old model (3G5U) is always shown in grey, new model (4M1M) is always shown in red):
1)
Elbow Helix 1 (EH1): The N-terminal "elbow" helix required a rotation of approximately 90˚ (~ one-residue shift in registry) in order to correctly model the large side chains of Phe39 and Tyr41 (see Fig. S2, panels A and B) into clear experimental density. Side chains for these two residues were previously modeled in positions unaccounted for by any electron density. Following corrections at the C-terminus of TM6 (discussed below), electron density for three more residues (30-32) was evident for modeling a new N-terminal coil of mouse Pgp. Contiguous electron density connecting the close side chains of Arg40 and Asp366 revealed a salt bridge with the Nterminal elbow and the bottom of TM6 (see Fig. S2 panel C).
2)
Transmembrane Helix 1 (TM1): The helical backbone of TM1 remains essentially unchanged, although the start of the helix was adjusted to allow a better fit of Trp44 (see Fig. S3 , panel A) into side chain density. A different rotameric configuration of Tyr49 (Panel B) was chosen to fit into very clear density. A slight adjustment of the backbone was made to allow Met74 (see 
4)
Intracellular Helix 1 (IH1): Significant remodeling of intracellular helix 1 (IH1) was required. The helix of TM2 clearly terminates at Asn153 as revealed by a slendering of the electron density for the 90˚ turn just prior to the start of IH1 (see Fig. S5 , panel A). Glu155 was previously modeled into a location with no electron density and its side chain hydrogen bonding with itself. Remodeling of the turn as a coil allowed placement of Gln154 and Glu155 into excellent density in which polar contacts with TM helices and Ser370 (NBD1) were revealed (see Fig. S5 , panels B and C). Regularization of IH1 (residues 155-161) allowed good placement of the side chains into electron density. Van der Waal contacts between the side chains of Gln154, Trp158 and His162 are evident as contiguous electron density above IH1 (see Fig. S5 panel D) .
5) Transmembrane Helix 3 (TM3):
The C-terminal half of TM3 required remodeling in the form of ~ 1-residue registry shift (~ 90˚ rotation): Backbone and side chain atoms of TM3 for roughly the first N-terminal half of the helix (residues 164-180) remained essentially unchanged. A break in TM3 helical ideality was clearly evident in our new experimental electron density map at Gly181, Ile182 and Gly183. This "G-X-G" motif is nearly invariant among drug transporters (ABCB1) and lipid flippases (ABCB4), and appears to allow flexibility in the form of a backbone "bulge" at Ile182 and Gly183. Proper modeling of the helical bulge in experimental electron density that also allows the Ile182 side chain to pack in a hydrophobic environment results in a registry shift of approximately one residue (see Fig. S6 ) for the remainder of the helix (184-204) compared to the original modeling.
6)
Extracellular Loop 2 (ECL2) and Transmembrane Helix 4 (TM4): Jin et al proposed a registry problem in mouse Pgp TM4 based on an alignment with the higher resolution C. elegans Pgp structure (2) . Inspection of the original electron density maps as well as our new experimental map revealed that extracellular loop 2 (ECL2) of mouse Pgp including the large side chain of Trp208 were originally modeled without any convincing electron density representation. Furthermore, Trp208 is conserved among all P-glycoprotein orthologs, and the position of the corresponding residue in C. elegans (Trp236) served as an important landmark for remodeling mouse Pgp TM4. We remodeled ECL2 as a shorter loop that fit well in electron density, and also placed the Trp208 side chain into very clear density to start the TM helix (see Fig. S7 , panels A and B). A canonical helix representing TM4 fit well into the density with the new chosen position of Trp208 and revealed a 4-residue registry shift (~ one entire helical turn) for the entire TM4 (see Fig. S7 panel C) . TM4 of C. elegans Pgp was modeled as a contiguous helix all the way down to the turn into intracellular helix 2 (IH2). The original modeling of mouse Pgp in this region is quite different with the helix breaking prior to IH3 and 8 residues (249-256) modeled as a coil. Careful inspection of our new experimental maps clearly show this region calls for a helix all the way to IH2.
7)
Intracellular Helix 2 (IH2): IH2 (residues 256-264) remains essentially unchanged because the registry problem of TM4 was corrected at its N-terminus and modeling TM4 C-terminus as a helix picked up the slack, calling for the start of IH2 at the same original residue (Ala256). Fitting Phe263 near the end of IH2 into clear side chain density (see 
elegans
Pgp-1 structure. Notably, the C. elegans Pgp-1 structure is open to the cytoplasm by an additional 15 Å compared to mouse Pgp. Since several of the large amino acid side chains of TM5 are conserved between mouse Pgp and C. elegans Pgp-1, modeling of each is deemed highly accurate. We propose that the difference between mouse Pgp and C. elegans Pgp-1 TM5 reveals a genuine rotation of TM5 as the transporter opens more fully to envelope large substrates. All-atom molecular dynamics simulations are likely to shed more light on the highly flexible nature of these transporters, and identify more specific roles of residues and entire TM helices that relieve overall strain during the transport cycle.
9) Extracellular Loop 3 (ECL3):
The modeling of extracellular loop 3 (ECL3) was improved by fitting the backbone as well as the side chain of Tyr322 into very clear side chain density (see Fig. S10 ).
10)
Transmembrane Helix 6 (TM6): Mouse Pgp TM6 remains essentially unchanged. A slight rotation of the helix (less than 5˚) allowed fitting of a proper rotamer of Phe331 into clear side chain density. A very clear "lobster claw" of density is evident for Phe331 and the following drugbinding residue Phe332 (see Fig. S11, panel A) . Considering the necessary changes to the very N-terminus of mouse Pgp and the elbow helix, the previous modeling of the Tyr359 side chain near the C-terminal end of TM6 results in an excessive steric clash. Careful inspection of improved experimental electron density and the previous modeling of the helix in this region revealed that the helical backbone protruded out of density resulting in the incorrect positioning of the Tyr359 side chain. A "tightening" of the TM6 backbone to fit into density (see Fig. S11 , panel C) allows a proper rotamer of Tyr359 and all remaining residues of TM6 (360-367) to fit into electron density (see Fig. S11, panel B) , including a clearly visible salt bridge between Asp366 and the elbow helix residue Arg40 (see Fig. S11 , panel D).
11) TM6-NBD1 connector:
A problem with the modeling of the connection between TM6 and NBD1 was noticed particularly from the incorrect positioning of the Phe374 side chain. Close inspection of new experimental electron density prompted complete remodeling (see Fig. S12 , panels A, B and C) of this region (residues Lys368 -Gln385).
12)
Nucleotide Binding Domain 1 (NBD1): The position of the entire NBD1 remains essentially unchanged, although refinement resulted in improvements (see Fig. S13 ) to NBDs at various locations.
13)
Linker region: Improved phases did not reveal any more density corresponding to residues for the linker region (positions 627-687).
14)
Elbow Helix 2 (EH2): As with elbow helix 1 (EH1), EH2 required remodeling. Roughly half of the backbone of EH2 (residues 694-702) in the original modeling was completely out of density. Regularization as well as a rotation and translation were required to fit the backbone completely into density (see Fig. S14 ) as well as a significantly improved fit for the side chain of Trp694.
15) Transmembrane Helix 7 (TM7):
Clear experimental electron density reveals that the start of TM7 was incorrectly modeled since Trp704 had no experimental electron density representation. Density also revealed that the helix should start lower, with Trp704 forming the initial helical hydrogen bonding network. Repositioning Trp704 to start TM7 (see Fig. S15 ) also allowed a perfect fit of the side chain into experimental density. Refinement resulted in minor improvements to TM7 sidechains, but the helical registry remains unchanged.
16) Extracellular Loop 4 (ECL4) and Transmembrane Helix 8 (TM8):
Experimental electron density from our new map is discontinuous for extracellular loop 3 (ECL3), making it difficult to comment on previous modeling of this region. However, ECL3 is clearly involved in forming crystal contacts and the direct residues involved in contact must, by definition, be reasonably well ordered. Indeed, inspection of our new experimental map reveals clear side chain density for a residue that is in direct contact with the NBD of another Pgp molecule. Pro741 was previously modeled in this position, but has no side chain to make the contact. "Pulling" the loop down, would position Pro740 in this location, resulting in the same problem. Pulling the loop up would place Glu742 in this position, providing a potential solution with a reasonable good fit into the density. Making such a change would result in a one-residue registry shift for the entire TM8, assuming the helix remains ideal over the full span of residues. Careful inspection of new experimental electron density shows that TM8 at residues Leu758 and Gly759 was modeled as a bulge in the helix protruding slightly out of backbone density. A "tightening" of the helix at this point allowed remodeling and registry correction for residues from Glu742 to Glu759. The remainder of TM8 is in proper registry alignment, and includes improvements in the placement of many side chains, including Phe763, Phe771, Phe773, Glu778, Arg785 and Tyr786 (see Fig. S16 panels A through E).
17) Intracellular helix 3 (IH3):
The positioning of IH3 (residues 795-805) is essentially correct, however experimental electron density called for a more regularized helix than what was originally modeled. Re-modeling IH3 as a regular helix resulted in a better side chain fit of Trp799 and Phe800 into density (see Fig. S17 ).
18)
Transmembrane helix 9 (TM9): The position and registry of TM9 from residues 807-825 remain unchanged. A problem was observed with the previous modeling of residues 825-827 in which the backbone was wound very tight and places the Arg828 side chain in a region with no electron density whatsoever (see Fig. S18, panel A) and that also clashes with the new position of Trp694 (see Fig. S18, panel B) . A slight relaxation of the helix at 825-827 allowed fitting of Arg828 into very nice density that is contiguous with Tyr994 (see Fig. S18, panel C) , revealing a likely pication interaction with TM8 and TM12. The relaxation of the helix at 825-827 resulted in a ½residue registry shift (~45˚ rotation) that improved side chain fitting into experimental density for Arg828, Phe833, Gln834, Asn838, Leu839, Thr841, Ile843, Ile844, Leu847 and Tyr849 (see Fig.  S18, panel D) .
19)
Extracellular loop 5 (ECL5): ECL5 (residues 849-851) was previously modeled with a small portion of the backbone out of electron density and poor density representation for the large sidechain of Trp851. Re-modeling of the loop to fit into density allowed a proper rotameric choice of the Trp851 side chain to fit very well into density (see Fig. S19 ).
20)
Transmembrane helix 10 (TM10): The position and registry of TM10 (residues 852-898) remains unchanged, although refinement improved the fitting of most of the sidechains (see Fig.  S20 ) on this helix.
21)
Intracellular Helix 4 (IH4): IH4 (residues 899-908) were previously modeled as a coil in the shape of a helix with no proper hydrogen bond network in the backbone. The finding is evidence for an over-refined structure that was subjected to high thermal coefficients without proper restraints. Re-modeling of IH4 allowed perfect fit as a regular helix from residues 899-906 including perfect fit for all side chains including the easy-to-visualize large sidechain of Phe900 (see Fig. S21 ) that previously had no corresponding density. The correction represents a oneamino acid registry correction.
22)
Transmembrane helix 11 (TM11): The registry for the entire helix of TM11 (residues 909-962) remains unchanged from the original modeling, although refinement resulted in significant improvement in the placing of side chains for Met911, Glu113, Met915, Met928, Phe934, Phe938, Tyr946, Phe955 and Gln962 (see Fig. S22, panels A, B and C) .
23) Extracellular loop 6 (ECL6):
The original modeling of the backbone of ECL6 (residues 963-967) strays rather wildly out of experimental electron density (see Fig. S23 panel B) as revealed by our new map. Careful inspection reveals that the very C-terminus of TM11 actually calls for another complete turn of a helix, effectively "pulling" more residues of ECL6 toward real density. After completing another helical turn concluding TM11, ECL6 could easily be modeled into the contiguous density that includes a decent fit of the Phe967 side chain into density (see Fig. S23 , panels A and C).
24)
Transmembrane helix 12 (TM12): TM12 (residues 968-1010) consists of important drug binding residues, yet is not well conserved between C. elegans Pgp-1 and mammalian Pgp orthologs. Careful inspection of experimental electron density revealed that the original modeling of TM12 included a gradual and increasing registry shift which resulted in an offset of a full turn (90˚ rotation) for 12 residues starting at position 976 down to the "break out" loop (Val987) midway through the helix. The problem was corrected by a de novo rebuild of residues 968-987, which fit electron density very well particularly for the large side chains of Phe974, Phe979 and Met982 which previously had virtually no density representation (see Fig. S24, panels A, B and C) . The break out loop was incorrectly modeled as revealed by protrusion of the backbone at residue Asp993 out of density (see Fig. S24 panel E) . Correct modeling of the breakout loop keeps the remaining residues of the helix (994-1010) essentially the same as they were previously modeled (see Fig. S24, panel D) .
25)
TM12-NBD2 connector: The connector (residues 1009-1028) required a complete rebuild since most of the region had poor electron density representation in our new experimental map. Obvious improvements include the backbone of the entire section fitting into electron density as well as good coverage of most side chains including Tyr1017 (see Fig. S25, panels A and B) .
26)
Nucleotide Binding Domain 2 (NBD2): The overall positioning of the backbone of NBD2 remains unchanged, however refinement improved the fit of side chains into density, for example: Leu 1109 and Arg1218 (see Fig. S26 , panels A and through C) as well as the fit of side chains into density that previous had poor electron density representation: Phe1091, Lys 1098, and Phe1119 (see Fig. S26 , panels D through F). Table S3 . Table S4 . Cross-correlation analysis of models vs. experimental electron density maps. Correlation coefficients of models for the corrected mouse Pgp structure (4M1M) and the original structure (3G5U) were calculated for both the newly calculated single-anomalous dispersion (SAD) phased map and the original multiwavelength anomalous dispersion (MAD) phased map. Values were achieved using phenix.get_cc_mtz_pdb. For comparison, an unsharpened (b_iso=0) SAD map (column labeled "SAD unsharpened") exhibited very similar real space correlation to the corrected mouse Pgp modeled compared to the modestly sharpened map ("SAD map"; b_iso=-38) we used for modeling. Over-sharpening ("SAD over-sharpened"; b_iso=-78) resulted in less favorable correlation in real space. , an attempt to correct mouse Pgp (PDB 4LSG), and structure of the double mutant (A981C/A983C) labeled with mercury. TM12 is highlighted in orange. TM7 and a portion of TM8 & TM9 (residues 694:741; 760:794; 805:827 shown in green) were used to align 3G5U, 4LSG and 4M1M to the refined isomorphous (see Table S7 below) structure of A981C/A983C. These TMs were chosen to produce a highly precise alignment because the original structure contained no registry errors in this region. Panels B-D: wall-eyed stereo views. Figure S31 . Phylogenetic analysis of P-glycoprotein. Vertebrate P-glycoprotein group into one tightly defined phylogenetic cluster (boxed in green) that is distinct from the many C. elegans PGP-X orthologs. C. elegans PGP-1, PGP-2 and PGP-9 (boxed in blue) are the closest of the nematode PGPs to be related to vertebrate Pgp, yet none is higher than 42% identity with any vertebrate Pgp. Chicken ABCB1, however is 70% identical to human Pgp, revealing a major jump in divergence in nematodes. a Rsym = Σ|I--<I>|Σ<I>, where I is the measured intensity of each reflection, and <I> is the intensity averaged from symmetry equivalents. 
